Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes | Zendy

Peter Stalmans | Zendy; Matthew S. Benz | Zendy; Arnd Gandorfer | Zendy; Anselm Kampik | Zendy; Aniz Girach | Zendy; Stephen Pakola | Zendy; Julia A. Haller | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes

Author(s) -

Peter Stalmans,

Matthew S. Benz,

Arnd Gandorfer,

Anselm Kampik,

Aniz Girach,

Stephen Pakola,

Julia A. Haller

Publication year - 2012

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1110823

Subject(s) - medicine , posterior vitreous detachment , vitrectomy , macular hole , ophthalmology , visual acuity , placebo , epiretinal membrane , surgery , pathology , alternative medicine

Vitreomacular adhesion can lead to pathologic traction and macular hole. The standard treatment for severe, symptomatic vitreomacular adhesion is vitrectomy. Ocriplasmin is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research